About

We founded Neumora to pioneer a new era in neuroscience by taking a fundamentally different approach to the way treatments for brain diseases are developed. Neuropsychiatric disorders and neurodegenerative diseases are heterogeneous, presenting with diverse symptoms and multiple underlying disease drivers. We’re focused on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. We are also leveraging a precision medicine approach to better understand the biological drivers of brain diseases and to identify targeted patient populations of interest. 

Neumora is relentless in its commitment to discovering, developing, and commercializing novel therapies for the 1.5 billion people living with brain diseases.